These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22984596)

  • 1. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays.
    Guasch L; Ojeda MJ; González-Abuín N; Sala E; Cereto-Massagué A; Mulero M; Valls C; Pinent M; Ardévol A; Garcia-Vallvé S; Pujadas G
    PLoS One; 2012; 7(9):e44971. PubMed ID: 22984596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (Part II): in silico prediction in antidiabetic extracts.
    Guasch L; Sala E; Ojeda MJ; Valls C; Bladé C; Mulero M; Blay M; Ardévol A; Garcia-Vallvé S; Pujadas G
    PLoS One; 2012; 7(9):e44972. PubMed ID: 23028712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening.
    Ojeda-Montes MJ; Gimeno A; Tomas-Hernández S; Cereto-Massagué A; Beltrán-Debón R; Valls C; Mulero M; Pujadas G; Garcia-Vallvé S
    Med Res Rev; 2018 Sep; 38(6):1874-1915. PubMed ID: 29660786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening.
    Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S
    J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of dipeptidyl peptidase IV inhibitors: virtual screening, synthesis and biological evaluation.
    Xing J; Li Q; Zhang S; Liu H; Zhao L; Cheng H; Zhang Y; Zhou J; Zhang H
    Chem Biol Drug Des; 2014 Sep; 84(3):364-77. PubMed ID: 24674599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of human IKK-2 inhibitors of natural origin (part I): modeling of the IKK-2 kinase domain, virtual screening and activity assays.
    Sala E; Guasch L; Iwaszkiewicz J; Mulero M; Salvadó MJ; Pinent M; Zoete V; Grosdidier A; Garcia-Vallvé S; Michielin O; Pujadas G
    PLoS One; 2011 Feb; 6(2):e16903. PubMed ID: 21390216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening of dipeptidyl peptidase-4 inhibitors using quantitative structure-activity relationship-based artificial intelligence and molecular docking of hit compounds.
    Hermansyah O; Bustamam A; Yanuar A
    Comput Biol Chem; 2021 Dec; 95():107597. PubMed ID: 34800858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Patel BD; Bhadada SV; Ghate MD
    Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4.
    Mishra A; Cross M; Hofmann A; Coster MJ; Karim A; Sattar A
    J Comput Biol; 2019 Dec; 26(12):1470-1486. PubMed ID: 31390221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV.
    Pascual Alonso I; Valiente PA; Valdés-Tresanco ME; Arrebola Y; Almeida García F; Díaz L; García G; Guirola O; Pastor D; Bergado G; Sánchez B; Charli JL
    Int J Biol Macromol; 2022 Jan; 196():120-130. PubMed ID: 34920066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
    Juillerat-Jeanneret L
    J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors.
    Upadhyay J; Gajjar A; Suhagia BN
    Curr Drug Discov Technol; 2019; 16(4):426-436. PubMed ID: 30255759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Biological Evaluation, and QPLD Studies of Piperazine Derivatives as Potential DPP-IV Inhibitors.
    Khalaf RA; Jarad HA; Al-Qirim T; Sabbah D
    Med Chem; 2021; 17(9):937-944. PubMed ID: 32940185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.
    Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ
    Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among
    Yang Y; Shi CY; Xie J; Dai JH; He SL; Tian Y
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31906524
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity.
    Nongonierma AB; FitzGerald RJ
    Peptides; 2016 May; 79():1-7. PubMed ID: 26988873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening and in vitro assays of novel hits as promising DPP-4 inhibitors.
    Pantaleão SQ; Philot EA; de Paula H; Inês de Sairre M; Lima AN; Pires LM; Alves Dos Santos R; Scott AL; Honorio KM
    Biochimie; 2022 Mar; 194():43-50. PubMed ID: 34952193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of in vitro angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitory peptides from draft beer by virtual screening and molecular docking.
    Wenhui T; Shumin H; Yongliang Z; Liping S; Hua Y
    J Sci Food Agric; 2022 Feb; 102(3):1085-1094. PubMed ID: 34309842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in natural products as DPP-4 inhibitors.
    Gao Y; Zhang Y; Zhu J; Li B; Li Z; Zhu W; Shi J; Jia Q; Li Y
    Future Med Chem; 2015; 7(8):1079-89. PubMed ID: 26062402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening strategy for anti-DPP-IV natural flavonoid derivatives based on machine learning.
    Lu G; Pan F; Li X; Zhu Z; Zhao L; Wu Y; Tian W; Peng W; Liu J
    J Biomol Struct Dyn; 2024 Aug; 42(13):6645-6659. PubMed ID: 37489054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.